CORRESP Filing
PALISADE BIO, INC.
Date: Aug. 26, 2025 · CIK: 0001357459 · Accession: 0001641172-25-025568
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289635
Letter
August 26, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Mail Stop 4561
F Street, N.E.
Washington, D.C. 20549-3720
Attention: Joshua Gorsky
Re: Palisade Bio, Inc. Registration Statement on Form S-3 Filed August 15, 2025
File No. 333-289635
Ladies and Gentlemen:
Pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, Palisade Bio, Inc. (the " Company ") hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-289635) (the " Registration Statement ") be declared effective at 4:00 p.m., Eastern Time on Thursday, August 28, 2025.
The Company hereby authorizes Jeffrey Thacker of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Company to orally modify or withdraw this request for acceleration.
Thank you for your assistance. If you should have any questions, please contact Jeffrey Thacker of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Company at (858) 436-8064.
[Signature page follows]
Securities and Exchange Commission
August 26, 2025
Page
Sincerely,
Palisade
Bio, Inc.
Show Raw Text
CORRESP 1 filename1.htm August 26, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Mail Stop 4561 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Joshua Gorsky Re: Palisade Bio, Inc. Registration Statement on Form S-3 Filed August 15, 2025 File No. 333-289635 Ladies and Gentlemen: Pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, Palisade Bio, Inc. (the " Company ") hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-289635) (the " Registration Statement ") be declared effective at 4:00 p.m., Eastern Time on Thursday, August 28, 2025. The Company hereby authorizes Jeffrey Thacker of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Company to orally modify or withdraw this request for acceleration. Thank you for your assistance. If you should have any questions, please contact Jeffrey Thacker of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Company at (858) 436-8064. [Signature page follows] Securities and Exchange Commission August 26, 2025 Page 2 Sincerely, Palisade Bio, Inc. By: /s/ JD Finley JD Finley Chief Executive Officer Palisade Bio, Inc. cc: Jeffrey C. Thacker, Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP Ryan J. Gunderson, Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP John E. Maciejewski, Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP